By Stewart Bishop ( March 8, 2012, 9:32 PM EST) -- GlaxoSmithKline PLC asked the U.S. Supreme Court last month to review a decision that upheld Classen Immunotherapies Inc.'s patents for evaluating a vaccine immunization schedule, arguing the Federal Circuit wrongly ruled on a statute covering exemptions meant to protect parties from infringement liability....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.